Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic...

40
Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels, Belgium & International Society of Antiinfective Pharmacology Advances in the Pharmacology of Antiinfective Therapy, Bangalore, India, January 20-22, 2000

Transcript of Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic...

Page 1: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of

New Chemotherapeutic Agents

Paul M. Tulkens, MD, PhDCellular and Molecular Pharmacology Unit

Catholic University of Louvain, Brussels, Belgium&

International Society of Antiinfective Pharmacology

Advances in the Pharmacology of Antiinfective Therapy,

Bangalore, India, January 20-22, 2000

Page 2: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

What is Intracellular Infection ?

The Cell

(black box)

antibiotic bacteria

Page 3: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

These they are… OBLIGATORY OR MAINLY INTRACELLULAR:

respiratory infections (pneumopathies): Chlamydia pneumoniae: 10% in children

Legionella pneumophila: frequent if immunosuppression Mycobacterium spp.: frequent if immunosuppression

sexually transmitted diseases Chlamydia trachomatis: most common pathogen

CNS infections + other sites: Listeria monocytogenes: pregnant women;

immunosuppression

FACULTATIVE OR MAINLY EXTRACELLULAR: digestive tract infections

Salmonella spp., Shigella spp. respiratory, cutaneous, etc…tract infections

Streptococcus spp., Staphylococcus spp.

Page 4: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

1. where are the bacteria ? 2. which antibiotics accumulate in cells ?3. where are antibiotics located ?4. what is the intracellular expression of activity ?5. what is the bacterial responsiveness ? 6. cooperation with the cell own defenses and cytokines?

You need to consider (at least)the following questions:

Page 5: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

1st question (and answer) : where do intracellular bacteria sojourn and thrive ?

LegionellaChlamydia, ...

S. aureusSalmonella,M. leprae, ...

Listeria hly+,Shigella

phagosomesphagolysosomes

cytosol endosomes

Page 6: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Antibiotics and Intracellular Bacteria : a Bit of Theory

Eur. J. Microbiol Infect. Dis. 10: 100-106, 1991

Page 7: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

2d question (and answer): which antibiotics do accumulate in cells ?

• beta-lactams: 1x• aminoglycosides: <1 to 2 x• ansamycins: 2-3 x• tetracyclines: 2-4 x• fluoroquinolones: 10-20 x• macrolides: 4 to > 100 x

Page 8: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

endosomes?

phagosomes?

phagolysososomes• macrolides• aminoglycosides

cytosol• fluoroquinolones• beta-lactams• ansamycins

3d question (and answer) : where are intracellular antibiotics located ?

Page 9: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

endosomes

phagosomes• macrolides: reduced• aminoglycosides: very reduced

• fluoroquinolones: yes• ansamycins: excellent• beta-lactams: yes

4th question: what are the antibiotic intracellular expressions of activity

pH = 7

pH < 6

Page 10: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

in endosomes:?

in phagosomeslikely to excellent

5th question: what is the bacterial responsiveness to the antibiotics ?

pH = 7

pH < 6

in cytosol:excellent

in phagolysosomes:very variable

Page 11: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

in endosomes:likely

in phagosomeslikely

6th question [1 of 2]: cooperation with the cell own defenses ?

pH = 7

pH < 6

in cytosol:unlikely

in phagolysosomes:very variable

O2. -

NO.

myeloperoxydaseacidity, cationic proteins...

Page 12: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

6th question [2 of 2]: cooperation or antagonism with the actions of cytokines ?

The very black box

antibiotic

interferonsILxgrowth fact.TNF...

Page 13: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

antibiotics:

• ampicillin• sparfloxacin• azithromycin

interferongamma

Listeria monocytogeneshly+ and hly-

Page 14: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

INTRACELLULAR INFECTION CYCLE OF Listeria monocytogenes hly+

from Portnoy et al.

Page 15: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Bacteria are stained withfluorescein(FITC) [green]and cell actinwith phalloidinrhodamin[red];

hly+: virulenthly-: non virulent

Listeria and Interferon : confocal microscopy

Page 16: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

A: phagocytosisB: escape from vacuoleC: surrounded by actin

D,E: cells pre-treated with interferon-gamma, L. m. hly+ remains in vacuoles.

F,G, H: L.m. hly- remains constantly in vacuoles

A = 1 h post infection; B, C, D, F, G = 3 h post infection E, H = 5 h post infection

Following the intracellular fateof Listeria m. in EM

Page 17: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

control

IFN 100 U/ml

control

IFN 100 U/ml

IFN contains L. monocytogenes hly+ in phagosomes and impairs its growth.

A: dose-dependency; B: specifity

IFN 50 U/ml

IFN 100 U/m+ anti IFN IgG

Page 18: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

The growth containment of L. monocytogenes caused by

IFN is due to NO and H202 production...

Page 19: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

IFN and antibiotics...

control

+ IFN

+ IFN and

LMMA / catalase

Intracellular activity:

CFU @ 0 h CFU @ 5 hlog10

Bacterial growth

Bacterial kill

Page 20: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Listeria, ampicillin and Interferon gamma

1. Ampicillin is poorly active against intracellular Listeria;

2. Ampicillin activity is completely defeated when IFN is present (IFN makes the job !)

Why do you keep ampicillin ? extracellular bacteria get activity with very large doses

Page 21: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Listeria, fluoroquinolones and Interferon

-1

0

1

2

3

Intr

ac

ellu

lar

ac

tiv

ity

(lo

g(C

FU

0h

/5h

))

SPSP+

INF

CT

SP + INFSP + INF+ LMMA + + LMMA + catalasecatalase

sparfloxacin

(Ouadrhiri et al, 1999)

0

5

10

15

20

Ac

cu

mu

lati

on

fa

cto

r (C

c/C

e)

SP

SP + INFSP + INF+ LMMA + + LMMA + catalasecatalase

T = 5h

AccumulationActivity

SP+

INF

Page 22: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Listeria, fluoroquinolones and Interferon

1. Sparfloxacin appears highly active against intracellular Listeria;

2. Sparfloxacin activity is enhanced when IFN is present (IFN and Sp cooperate !)

Why don’t you use fluoroquinolones ? too low intrinsic activity ...

Page 23: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Where published ?

Scorneaux et al.,Antimicrob. Agents Chemother. 40:1225-30, 1996

Ouadrhiri et al., Antimicrob. Agents Chemother. 43:1242-51, 1999

Ouadrhiri et al., J. Infect. Dis. 180:1195-204, 1999

Page 24: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

C NO

COOH

R

CHN

O

COOH

H2N

CH3

CH3

D-alanine beta-lactam

Page 25: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

O

COOH

R

ALL beta-lactam have (and must have) a free carboxyl group

(or an equivalent acidic group [electron donor])

at appropriate distance from the C —— N bound

NC

Page 26: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

phagolysososomespH 5-6

exatracellularpH 7.4

Why do beta-lactams not accumulate in cells (1 of 2) ?

cytosolpH 7.2

Page 27: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Why beta-lactams do not accumulate in cells (2 of 2) ?

AH

A-

AH

A-

AH

A-

H+ H+

H+

Page 28: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

What if you are basic ?

B

BH+

B

BH+

B

BH+

H+ H+

H+

Page 29: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

O

CO- R

R

To get accumulation, make a basic beta-lactam...

NC

- NH2

Page 30: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

O

CO- NH-CH2-CH2-CH2-N (CH3)2

R

N-(3-dimethylaminopropyl)benzylpenicillamide...

NC

S

CH3

CH3

H

Page 31: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

N-(3-dimethylaminopropyl)benzylpenicillamide…

get accumulated in cells (5 to 10-fold concentrates in lysosomes

but…

is inactive because the amide linkage is not splitted by lysosomal enzymes...

Page 32: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

O

CO - O - CH2 - X - NH2

R

You need to make a chemically labile ester...

NC

S

CH3

CH3

H

Page 33: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

What you can do with old pivampicillin...

N

S

COO

CH 3O

CH3

HNC

O

NH2

OO

H2CO

C C

O

CH 3

CH3

CH3

C

N

S

CH3O

CH 3

HNC

O

NH2

N

S

COOH

CH 3O

CH3

HNC

O

NH3

OO

H2CO

C C

O

CH 3

CH3

CH3

C

N

S

CH3O

CH 3

HNC

O

NH3

ampicillin

pivampicillin

pH 7 pH < 6+

+

-

Page 34: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

0.0

0.5

1.0

Intr

ac

ellu

lar

ac

tiv

ity

(lo

g(C

FU

0h

/24

h))

0 1 2 3 4Time (h)

0

20

40

60

80

Ac

cu

mu

lati

on

fa

cto

r (

Cc

/Ce

)Old pivampicillin does bring ampicillin in cells...

free AMPIPIVAAMPI FROM PIVA

CT AMPI PIVA

T = 24h

(Fan et al, 1997)

Page 35: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Where published ?

Renard et al., J. Med. Chem. 29:1291-1293, 1986

Renard et al., Antimicrob. Agents Chemother. 31:410-416, 1987

Fan et al., Bioorg. Med. Chem. Letters 24:3107-3112, 1997

Page 36: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

Thanks to the crew ...

Zubida Bumkhalla (beta-lactams [chemistry])

Marie-Béatrice Carlier (macrolides, fluoroquinolones)

Huajuan Fan (betlactams [chemistry] )

Christine Renard (beta-lactams)

Yousef Ouadrhiri (Listeria, interferon, IL6, fluoroquinolones)

Isabelle Paternotte (beta-lactams [chemistry], efflux mech.)

Bernard Scorneaux (Listeria, interferon, fluoroquinolones)

Etienne Sonveaux (beta-lactams [chemistry] )

Andrée Zenebergh (lincosaminides, macrolides)

Page 37: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

But where do they work ?

Catholic University of LouvainFaculty of Medicine Brussels, Belgium

Page 38: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

But, where is this university?

Cellular and Molecular Pharmacology UnitCatholic University of Louvain, Belgium

http://www.md.ucl.ac.be/facm

Page 39: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

intracellularpharmacodynamics

AUIC

postantibiotic effect...

population pharmacokinetics

tissue concentrations

efficacy/toxicity ratios

http://www.isap.org

But don’t forget ISAP...

Page 40: Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.

intracellularpharmacodynamics

AUIC

postantibiotic effect...

population pharmacokinetics

tissue concentrations

efficacy/toxicity ratios

And thank you to Bangalore...